Showing 1081-1090 of 1560 results for "".
- Metabolism of Autism Reveals Developmental Originshttps://reachmd.com/news/metabolism-of-autism-reveals-developmental-origins/2463031/“Metabolism is the language that the brain, gut and immune system use to communicate, and autism occurs when the communication between these systems is changed,” added Naviaux. The cell danger response is primarily regulated by adenosine triphosphate (ATP) the
- Integrating RECIST and Clinician Approaches Boosts NSCLC Researchhttps://reachmd.com/news/integrating-recist-and-clinician-approaches-boosts-nsclc-research/2463014/A 2-pronged approach in the non–small cell lung cancer (NSCLC) space that includes evaluating patient therapeutic outcomes via Response Evaluation Criteria in Solid Tumors (RECIST) for clinical
- New Research Explains Mechanisms Behind Psoriatic Arthritishttps://reachmd.com/news/new-research-explains-mechanisms-behind-psoriatic-arthritis/2462958/(SACRAMENTO) A study by UC Davis Health showed how inflammatory proteins called cytokines take the brakes off synovial cell growth in joints, leading to the abnormal tissue accumulation that’s associated
- Biomarkers Identified for Successful Treatment of Bone Marrow Tumorshttps://reachmd.com/news/biomarkers-identified-for-successful-treatment-of-bone-marrow-tumors/2462893/CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University of Leipzig Medical Center and the Fr
- Discovering a Key Quality-Control Mechanism in DNA Replicationhttps://reachmd.com/news/discovering-a-key-quality-control-mechanism-in-dna-replication/2462526/Illustration of the 55LCC complex courtesy of Cameron Baines (Phospho Biomedical Animation). PHILADELPHIA – When cells in the human body divide, they must first make accurate copies of their DNA. The DNA re
- FDA Approves Second-Line Tislelizumab Monotherapy in Esophageal Cancerhttps://reachmd.com/news/fda-approves-second-line-tislelizumab-monotherapy-in-esophageal-cancer/2462506/Data from the phase 3 RATIONALE 302 trial (NCT03430843) supported the FDA approval of tislelizumab-jsgr as a treatment for those with previously treated unresectable or metastatic esophageal squamous cell carcinoma.The FDA has approved
- Full List of UK Top 10 Most Common Cancers in Men Compared to Womenhttps://reachmd.com/news/full-list-of-uk-top-10-most-common-cancers-in-men-compared-to-women/2462406/Cancer is a disease that occurs when abnormal cells grow and divide in the body. They can then spread to other tissues and organs. As with any medical condition, the sooner you spot symptoms and seek treatment the bett
- Preliminary Clinical Trial Results Show ‘Dramatic and Rapid’ Regression of Glioblastoma After Next Generation CAR-T Therapyhttps://reachmd.com/news/preliminary-clinical-trial-results-show-dramatic-and-rapid-regression-of-glioblastoma-after-next-generation-car-t-therapy/2462330/A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published today in
- Novel Treatment for Polycythemia Vera Shows Promise in Clinical Trialhttps://reachmd.com/news/novel-treatment-for-polycythemia-vera-shows-promise-in-clinical-trial/2457480/A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical tria
- FDA Grants Fast Track Designation to BXCL701 for mCRPC Phenotypehttps://reachmd.com/news/fda-grants-fast-track-designation-to-bxcl701-for-mcrpc-penotype/2457211/The FDA has granted a fast track designation to the investigational oral innate immune activator BXCL701 in combination with a checkpoint inhibitor for the treatment of patients with metastatic small cell neuroendocrine prostate cancer (SCNC) who experienced progression on chemother